Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaledonia Regulatory News (CLDN)

Share Price Information for Caledonia (CLDN)

Share Price is delayed by 15 minutes
Get Live Data
383.00    2.00 (0.52%)
Bid:
378.00
Ask:
384.50
Spread: 6.50 (1.72%)
Market Cap: £1.96b
CLDN Live PriceLast checked at - London Stock Exchange

Intraday Caledonia Share Chart

Director/PDMR Shareholding

14 Mar 2023 17:35

RNS Number : 9514S
Caledonia Investments PLC
14 March 2023
 

Caledonia Investments plc

 

Notification of transactions of persons discharging managerial responsibilities ("PDMR") or persons closely associated with them ("PCA")

 

Caledonia Investments plc ("Caledonia" or the "Company") has been notified pursuant to the requirements of the Market Abuse Regulation of the following transactions in its ordinary shares of 5p ("Shares") involving Jamie Cayzer-Colvin, a director and a person closely associated with him.

 

On 13 March 2023, Jellicoe No.2 Settlement - Grandchildren's Fund, of which Mr Cayzer-Colvin is a trustee, transferred 2,415 Shares in Caledonia, representing 0.004% of the Company's total issued ordinary share capital, to a beneficiary for nil consideration.

 

Mr Cayzer-Colvin's total interests in Shares following the above transaction is as follows: 

 

Beneficial - 250,024 Shares = 0.46%

Non-beneficial - 200,969 Shares = 0.37%

Performance share scheme awards - 74,708 Shares = 0.14%

Deferred bonus plan awards - 9,097 Shares = 0.02%

 

Further information required by the Market Abuse Regulation in relation to these transactions is set out in the appendix below.

 

Enquiries:

Richard Webster

Company Secretary

Tel: +44 20 7802 8080

 

14 March 2023

 

APPENDIX

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Jellicoe No.2 Settlement - Grandchildren's Fund

2

 

Reason for the notification

 

a)

 

Position/status

 

Person closely associated with James Cayzer-Colvin, a director

 

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Caledonia Investments plc

b)

 

LEI

 

2138002FX1MYCA5ZZH32

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary 5p shares

 

 

GB0001639920

 

b)

 

Nature of the transaction

 

Transfer to beneficiary

 

c)

 

 

Price(s) and volume(s)

 

 

 

 

 

Price(s)

 

Volume(s)

£nil

2,415

 

d)

 

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

 

n/a single tranaction

e)

 

Date of the transaction

 

13 March 2023

f)

 

Place of the transaction

 

London - outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBRGDXSXBDGXS
Date   Source Headline
8th Jan 201910:02 amRNSReport for the quarter ended 31 December 2018
8th Jan 201910:00 amRNSNet Asset Value(s)
2nd Jan 20198:31 amRNSBlock listing Interim Review
21st Dec 20189:04 amRNSAcquisition
19th Dec 201810:40 amRNSReclassification of AIC sector
19th Dec 20188:28 amRNSHalf-year Report
6th Dec 20189:47 amRNSNet Asset Value(s)
22nd Nov 20187:00 amRNSHalf-year Report
19th Nov 20182:45 pmRNSDirector Declaration
15th Nov 20187:00 amRNSDirectorate Change
7th Nov 20189:09 amRNSNet Asset Value(s)
23rd Oct 20187:48 amRNSDisposal
15th Oct 20187:00 amRNSAcquisition
4th Oct 20181:57 pmRNSNet Asset Value(s)
6th Sep 20189:41 amRNSNet Asset Value(s)
1st Aug 20181:43 pmRNSPortfolio Update
19th Jul 201812:52 pmRNSResult of AGM
16th Jul 201811:28 amRNSDirectorate Change
13th Jul 20187:49 amRNSAcquisition
6th Jul 201810:34 amRNSReport for the quarter ended 30 June 2018
6th Jul 201810:31 amRNSNet Asset Value(s)
2nd Jul 20188:35 amRNSBlock listing Interim Review
28th Jun 201811:34 amRNSHolding(s) in Company
19th Jun 20189:12 amRNSAnnual Financial Report
6th Jun 201812:47 pmRNSNet Asset Value(s)
31st May 20185:11 pmRNSTotal Voting Rights
31st May 20183:00 pmRNSDirector/PDMR Shareholding
31st May 20189:17 amRNSDirector/PDMR Shareholding
25th May 20185:02 pmRNSTransaction in Own Shares
24th May 20185:11 pmRNSFinal Results - Correction
24th May 20187:00 amRNSFinal Results
4th May 201810:31 amRNSNet Asset Value(s)
13th Apr 20184:31 pmRNSHolding(s) in Company
9th Apr 201811:51 amRNSNet Asset Value(s)
29th Mar 20183:33 pmRNSTransaction in Own Shares
6th Mar 201810:03 amRNSNet Asset Value(s)
15th Feb 20183:14 pmRNSDirector/PDMR Shareholding
6th Feb 20181:14 pmRNSNet Asset Value(s)
8th Jan 201812:31 pmRNSDirector/PDMR Shareholding
5th Jan 20181:24 pmRNSReport for the quarter ended 31 Dec 2017
5th Jan 20181:19 pmRNSNet Asset Value(s)
2nd Jan 20189:49 amRNSBlock listing Interim Review
20th Dec 201710:44 amRNSDirector/PDMR Shareholding
12th Dec 20178:57 amRNSHalf-year Report
6th Dec 201712:20 pmRNSNet Asset Value(s)
30th Nov 20175:29 pmRNSDirector/PDMR Shareholding
30th Nov 201711:39 amRNSDirectorate Change
23rd Nov 20177:00 amRNSHalf-year Report
6th Nov 20173:23 pmRNSNet Asset Value(s)
1st Nov 20179:24 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.